339 related articles for article (PubMed ID: 20588182)
1. Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.
Xu Y; Tang T; Ding Y; Yao R; Xie J; Liao M; Xiao H; Chen Y; Yu X; Fu M; Liao Y; Zhao G; Cheng X
Am J Med Sci; 2010 Aug; 340(2):121-7. PubMed ID: 20588182
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin attenuates atrial structural remodelling in rats with myocardial infarction through the inhibition of the p38 MAPK signalling pathway.
Wang M; Li Z; Zhang X; Xie X; Zhang Y; Wang X; Hou Y
Heart Lung Circ; 2015 Apr; 24(4):386-94. PubMed ID: 25613240
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin changes cytokine expressions in ischemic territory and preserves heart function after acute myocardial infarction in rats.
Hu X; Sun A; Xie X; Huang Z; Jia J; Yao R; Ge J
J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):162-76. PubMed ID: 23139358
[TBL] [Abstract][Full Text] [Related]
4. Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.
Li Y; Wang Q; Zhou J; Xu Q; Chu X; Sun T; Liu X; Cai S
Eur J Pharmacol; 2014 Jan; 723():23-8. PubMed ID: 24333476
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin prevents myocardial necrosis in an experimental model of acute myocardial infarction.
Dourado PM; Tsutsui JM; Landim MB; Casella Filho A; Galvao TF; Aiello VD; Mathias W; da Luz PL; Chagas AC
Braz J Med Biol Res; 2011 May; 44(5):469-76. PubMed ID: 21445530
[TBL] [Abstract][Full Text] [Related]
6. Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats.
Huang D; Wang FB; Guo M; Li S; Yan ML; Yu T; Wei M; Li JB
Int J Mol Med; 2015 Mar; 35(3):829-38. PubMed ID: 25524396
[TBL] [Abstract][Full Text] [Related]
7. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
8. Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction - a pilot study.
Chitose T; Sugiyama S; Sakamoto K; Shimomura H; Yamashita T; Hokamaki J; Tsunoda R; Shiraishi S; Yamashita Y; Ogawa H
Atherosclerosis; 2014 Nov; 237(1):251-8. PubMed ID: 25262434
[TBL] [Abstract][Full Text] [Related]
9. Effect of targeting mitogen-activated protein kinase on cardiac remodeling in rats.
Baraka A; Mikhail M; Guemei A; El Ghotny S
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):339-46. PubMed ID: 19903984
[TBL] [Abstract][Full Text] [Related]
10. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
11. Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy.
Chang SA; Kim YJ; Lee HW; Kim DH; Kim HK; Chang HJ; Sohn DW; Oh BH; Park YB
Hypertension; 2009 Sep; 54(3):591-7. PubMed ID: 19564547
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin regulates myocardial cytokine expression and improves ventricular remodeling in rats after acute myocardial infarction.
Zhang J; Cheng X; Liao YH; Lu B; Yang Y; Li B; Ge H; Wang M; Liu Y; Guo Z; Zhang L
Cardiovasc Drugs Ther; 2005 Jan; 19(1):13-21. PubMed ID: 15883752
[TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.
Habibi J; Whaley-Connell A; Qazi MA; Hayden MR; Cooper SA; Tramontano A; Thyfault J; Stump C; Ferrario C; Muniyappa R; Sowers JR
Endocrinology; 2007 May; 148(5):2181-8. PubMed ID: 17317778
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF.
Zaitone SA; Abo-Gresha NM
Eur J Pharmacol; 2012 Sep; 691(1-3):134-42. PubMed ID: 22732653
[TBL] [Abstract][Full Text] [Related]
15. [Effects of pravastatin, fosinopril and their combination on myocardium TNF-alpha expression and ventricular remodeling after myocardial infarction in rats].
Wei M; Gu SM; Zhang YY; Wu YH; Wu ZG
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):444-7. PubMed ID: 15932706
[TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
Okada Y; Yamaguchi K; Nakajima T; Nishikawa T; Jo M; Mitsumoto Y; Kimura H; Nishimura T; Tochiki N; Yasui K; Mitsuyoshi H; Minami M; Kagawa K; Okanoue T; Itoh Y
Liver Int; 2013 Feb; 33(2):301-11. PubMed ID: 23295058
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effect of mangiferin on left ventricular remodeling in rats.
Zheng D; Hou J; Xiao Y; Zhao Z; Chen L
Pharmacology; 2012; 90(1-2):78-87. PubMed ID: 22759807
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells.
Kim YS; Ahn Y; Hong MH; Kim KH; Park HW; Hong YJ; Kim JH; Kim W; Jeong MH; Cho JG; Park JC; Kang JC
J Cardiovasc Pharmacol; 2007 Jun; 49(6):376-83. PubMed ID: 17577102
[TBL] [Abstract][Full Text] [Related]
19. Effects of HMG-CoA reductase inhibitor on experimental autoimmune myocarditis.
Liu X; Li B; Wang W; Zhang C; Zhang M; Zhang Y; Xia Y; Dong Z; Guo Y; An F
Cardiovasc Drugs Ther; 2012 Apr; 26(2):121-30. PubMed ID: 22382902
[TBL] [Abstract][Full Text] [Related]
20. [Rosuvastatin improves myocardial function and arteriosclerosis plaque in patients with ST-segment elevation after acute myocardial infarction and percutaneous coronary intervention].
Lin ZP; Shu PC; Liao ZJ; Wang XQ; Liu Q
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1789-91. PubMed ID: 22027793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
